Clinical toxicology · 1968 · 41 citations · 22 references
PharmacyPharmacokineticsPharmacologyClinical PharmacologyDrug MetabolismPediatric Clinical PharmacologyDrug DispositionPediatric Drug EliminationPediatric PharmacokineticsPediatric PharmacologyBiotransformationChild PharmacokineticsDrug Absorption In ChildrenDrug Half-life In ChildrenInfant Drug EliminationPediatric Drug AbsorptionPharmacokinetics In InfancySalicylate Metabolism
It would be reasonable to assume that all o r most of the important aspects of the absorption, distribution, metabolism, and excretion of a long established and widely used group of drugs such as the salicylates (particularly aspirin and salicylic acid) have been fully elucidated many years ago. Surprisingly, this i s not the case. Detailed studies of the pharmacokinetics of salicylate absorption and elimination have been carried out only recently [1-3]. These studies have revealed that man eliminates salicylate relatively more slowly as the amount of the drug in the body i s increased. This effect is due to a limited biotransformation capacity which i s apparent also in the elimination of certain other drugs [4]. It has potentially important implications with respect to the causation and treatment of salicylate poisoning, particularly in in-fants and children. It is appropriate therefore to summarize the available knowledge of salicylate elimination in man and to present some results of recent studies of salicylate pharmacokinetics in intoxicated infants and children.
22
Rapid determination of salicylate in biological fluids
P. Trinder · Biochemical Journal · 1954 · 627 citations · Full text
Pharmacokinetics of Salicylate Elimination in Man
Gerhard Levy · Journal of Pharmaceutical Sciences · 1965 · 283 citations
Insufficient parahydroxylation as a cause of diphenylhydantoin toxicity
Henn Kutt, Michael Wolk, Rolf Scherman et al. · Neurology · 1964 · 179 citations
Alan K. Done · PEDIATRICS · 1960 · 176 citations